Related Experiment Video
Updated: Apr 7, 2026

04:04
Asthma Detection Research Based on Voice Signal Processing and Machine Learning
Published on: July 22, 2025
1.2K
Smart Technology in Lung Disease Clinical Trials
Nancy L Geller1, Dong-Yun Kim1, Xin Tian1
1Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Chest
|July 3, 2015
Summary
Smart technology, including electronic health records and mobile devices, enhances lung disease clinical trials. This innovation offers cost savings and improved efficiency for researchers and patients.
Area of Science:
- Pulmonology
- Medical Informatics
- Clinical Trial Management
Background:
- Traditional clinical trials for lung diseases face challenges in efficiency and cost.
- Smart technology offers potential solutions to streamline trial processes.
Purpose of the Study:
- To describe the application of smart technology in lung disease clinical trials.
- To explore the benefits and drawbacks of using digital tools in research.
Main Methods:
- Utilizing electronic health records for subject identification.
- Implementing electronic informed consent procedures.
- Employing internet and mobile devices for intervention delivery and data collection.
Main Results:
- Examples of smart technology integration in trials are provided.
- New electronic devices for health data collection are highlighted.
- Early-stage comparisons with conventional methods are noted.
Conclusions:
- Smart technology presents a powerful, albeit nascent, tool for advancing lung disease clinical trials.
- Further research is needed to fully evaluate its impact and optimize its use.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.4K
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
Chronic Obstructive Pulmonary Disease
3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K

